标题
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
作者
关键词
-
出版物
Nature Reviews Endocrinology
Volume 16, Issue 2, Pages 104-116
出版商
Springer Science and Business Media LLC
发表日期
2019-12-30
DOI
10.1038/s41574-019-0305-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- PROSTAGLANDIN F2-ALPHA EYE DROPS (BIMATOPROST) IN GRAVES’ ORBITOPATHY: A RANDOMISED CONTROLLED DOUBLE MASKED CROSSOVER TRIAL (BIMA TRIAL)
- (2019) Mohd Shazli Draman et al. THYROID
- Predictive score for the development or progression of Graves’ orbitopathy in patients with newly diagnosed Graves’ hyperthyroidism
- (2018) Wilmar Wiersinga et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Global epidemiology of hyperthyroidism and hypothyroidism
- (2018) Peter N. Taylor et al. Nature Reviews Endocrinology
- Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy
- (2018) Giovanna Rotondo Dottore et al. JAMA Ophthalmology
- Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial
- (2018) Rathie Rajendram et al. Lancet Diabetes & Endocrinology
- Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial
- (2018) George J Kahaly et al. Lancet Diabetes & Endocrinology
- Gut microbiota in experimental murine model of Graves’ orbitopathy established in different environments may modulate clinical presentation of disease
- (2018) Giulia Masetti et al. Microbiome
- Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
- (2018) Jose V. Perez-Moreiras et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Mycophenolate mofetil contributes to downregulation of the hippocampal interleukin type 2 and 1β mediated PI3K/AKT/mTOR pathway hyperactivation and attenuates neurobehavioral comorbidities in a rat model of temporal lobe epilepsy
- (2018) Arindam Ghosh Mazumder et al. BRAIN BEHAVIOR AND IMMUNITY
- Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy
- (2018) Terry J Smith et al. ENDOCRINE REVIEWS
- Sino-Orbital Fungal Infection by Tilletiopsis minor, a Rare Human Pathogen, Diagnosed by Internal Transcribed Spacer Sequencing
- (2018) Kyle J. Godfrey et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy
- (2018) M. Marinò et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- B cells in Graves’ Orbitopathy: more than just a source of antibodies?
- (2018) Mario Salvi et al. EYE
- Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE)
- (2017) William Stohl Expert Review of Clinical Immunology
- Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy
- (2017) Sijie Fang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Teprotumumab for Thyroid-Associated Ophthalmopathy
- (2017) Terry J. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
- (2017) P. Perros et al. Orphanet Journal of Rare Diseases
- Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy
- (2017) Wilmar M Wiersinga Lancet Diabetes & Endocrinology
- Efficacy and safety of mycophenolate mofetil in patients with active moderate-to-severe Graves’ orbitopathy
- (2016) Xiaozhen Ye et al. CLINICAL ENDOCRINOLOGY
- Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen
- (2016) Utta Berchner-Pfannschmidt et al. ENDOCRINOLOGY
- MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves’ orbitopathy – lessons from randomized control trials
- (2016) Marius N Stan et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO
- (2016) Sijie Fang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs
- (2016) L. Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis
- (2016) Christine C. Krieger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hyperthyroidism
- (2016) Simone De Leo et al. LANCET
- Graves’ Disease
- (2016) Terry J. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective, systematically recorded mycophenolate safety data in Graves’ orbitopathy
- (2016) M. Riedl et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012
- (2015) Petros Perros et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Some studies on the natural history of Graves' orbitopathy: increase in orbital fat is a rather late phenomenon
- (2015) Peter W Potgieser et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Medical Treatment of Graves’ Orbitopathy
- (2015) M. Salvi et al. HORMONE AND METABOLIC RESEARCH
- Modeling Graves’ Orbitopathy in Experimental Graves’ Disease
- (2015) J. Banga et al. HORMONE AND METABOLIC RESEARCH
- Proteomics of Orbital Tissue in Thyroid-Associated Orbitopathy
- (2015) N. Matheis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bidirectional TSH and IGF-1 Receptor Cross Talk Mediates Stimulation of Hyaluronan Secretion by Graves' Disease Immunoglobins
- (2015) Christine C. Krieger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
- (2015) Marius N. Stan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
- (2015) Mario Salvi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy
- (2015) Seema Kumar et al. THYROID
- Breaking Tolerance to Thyroid Antigens: Changing Concepts in Thyroid Autoimmunity
- (2014) Sandra M. McLachlan et al. ENDOCRINE REVIEWS
- Possible Targets for Nonimmunosuppressive Therapy of Graves' Orbitopathy
- (2014) L. Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease
- (2014) S. Tsui et al. JOURNAL OF IMMUNOLOGY
- Markers of Inflammation and Fibrosis in the Orbital Fat/Connective Tissue of Patients with Graves’ Orbitopathy: Clinical Implications
- (2014) Przemyslaw Pawlowski et al. MEDIATORS OF INFLAMMATION
- Treatment of Active Corticosteroid-Resistant Graves’ Orbitopathy
- (2014) Jose Vicente Pérez-Moreiras et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Smoking and thyroid
- (2013) Wilmar M. Wiersinga CLINICAL ENDOCRINOLOGY
- Cutting Edge: Retrobulbar Inflammation, Adipogenesis, and Acute Orbital Congestion in a Preclinical Female Mouse Model of Graves' Orbitopathy Induced by Thyrotropin Receptor Plasmid-in Vivo Electroporation
- (2013) Sajad Moshkelgosha et al. ENDOCRINOLOGY
- Acute thyroid eye disease (TED): Principles of medical and surgical management
- (2013) D H Verity et al. EYE
- Effects of Prostaglandin F2α on Adipocyte Biology Relevant to Graves' Orbitopathy
- (2013) Mohd Shazli Draman et al. THYROID
- Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathy
- (2012) Terry J. Smith et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Orbit-Infiltrating Mast Cells, Monocytes, and Macrophages Produce PDGF Isoforms that Orchestrate Orbital Fibroblast Activation in Graves' Ophthalmopathy
- (2012) L. van Steensel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy
- (2012) L. Bartalena et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Public Health Relevance of Graves' Orbitopathy
- (2012) Katharina A. Ponto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Autoantibodies to the IGF1 Receptor in Graves' Orbitopathy
- (2012) Waldemar B. Minich et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Human fibrocytes coexpress thyroglobulin and thyrotropin receptor
- (2012) R. Fernando et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quality of Life in a German Graves Orbitopathy Population
- (2011) Katharina A. Ponto et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity
- (2011) S. Zang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adipose Tissue Depot-Specific Differences in the Regulation of Hyaluronan Production of Relevance to Graves' Orbitopathy
- (2011) Lei Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA
- (2011) Shuang-Xia Zhao et al. JOURNAL OF ENDOCRINOLOGY
- A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy
- (2011) S. Kumar et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Selenium and the Course of Mild Graves' Orbitopathy
- (2011) Claudio Marcocci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Relevance of Thyroid-Stimulating Immunoglobulins in Graves' Ophthalmopathy
- (2011) Katharina A. Ponto et al. OPHTHALMOLOGY
- Developmental Origins of the Adipocyte Lineage: New Insights from Genetics and Genomics Studies
- (2011) Nathalie Billon et al. Stem Cell Reviews and Reports
- Neutral Antibodies to the TSH Receptor Are Present in Graves’ Disease and Regulate Selective Signaling Cascades
- (2010) Syed A. Morshed et al. ENDOCRINOLOGY
- Regulatory T-Cells in Graves' Orbitopathy: Baseline Findings and Immunomodulation by Anti-T Lymphocyte Globulin
- (2010) George J. Kahaly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated Orbitopathy
- (2010) Luigi Bartalena JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Graves' Ophthalmopathy
- (2010) Rebecca S. Bahn NEW ENGLAND JOURNAL OF MEDICINE
- The Amsterdam Declaration on Graves' Orbitopathy
- (2010) Petros Perros et al. THYROID
- Effect of Smoking on Orbital Fat and Muscle Volume in Graves' Orbitopathy
- (2010) Noortje I. Regensburg et al. THYROID
- Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts
- (2009) Lei Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Role of 11ß-Hydroxysteroid Dehydrogenase 1 in Adipogenesis in Thyroid-Associated Ophthalmopathy
- (2009) Jeremy W. Tomlinson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Generation of Fibrocytes in Thyroid-Associated Ophthalmopathy
- (2009) Raymond S. Douglas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
- (2008) Luigi Bartalena et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy
- (2008) Luigi Bartalena et al. THYROID
- Regulation of Lymphocyte Function by PPARγ: Relevance to Thyroid Eye Disease-Related Inflammation
- (2008) G. M. Lehmann et al. PPAR Research
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started